Literature DB >> 11005750

Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models.

J B Pucilowska1, K L Williams, P K Lund.   

Abstract

The cellular mediators of intestinal fibrosis and the relationship between fibrosis and normal repair are not understood. Identification of the types of intestinal mesenchymal cells that produce collagen during normal healing and fibrosis is vital for elucidating the answers to these questions. Acute injury may cause normal mesenchymal cells to convert to a fibrogenic phenotype that is not maintained during normal healing but may lead to fibrosis when inappropriately sustained. Proliferation of normal or fibrogenic mesenchymal cells may lead to muscularis overgrowth associated with fibrosis. The presence of increased numbers of vimentin-positive cells within fibrotic, hypertrophied muscularis in Crohn's disease suggests that changes in mesenchymal cell phenotype and number may indeed be associated with fibrosis. Fibrosis is induced in rats by peptidoglycan polysaccharides or trinitrobenzene sulfonic acid-ethanol administration, but inducing fibrosis in mice has been technically challenging. The development of current mouse models of colitis, such as dextran sodium sulfate or trinitrobenzene sulfonic acid-ethanol administration, into models of fibrosis will allow us to use genetic manipulation to study molecular mediators of fibrosis.

Entities:  

Mesh:

Year:  2000        PMID: 11005750     DOI: 10.1152/ajpgi.2000.279.4.G653

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  57 in total

1.  Basement membrane components.

Authors:  A C Y Li; R P H Thompson
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

2.  Stellate cells in the digestive tract.

Authors:  Hendrik Reynaert; Filip Sermon; Daniel Urbain; Albert Geerts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 3.  Taming the elephant: Salmonella biology, pathogenesis, and prevention.

Authors:  Helene L Andrews-Polymenis; Andreas J Bäumler; Beth A McCormick; Ferric C Fang
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

4.  Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system.

Authors:  Takehisa Suekane; Yoshihiro Ikura; Kenji Watanabe; Junko Arimoto; Yoko Iwasa; Yoshimi Sugama; Soichiro Kayo; Kenichi Sugioka; Takahiko Naruko; Kiyoshi Maeda; Kosei Hirakawa; Tetsuo Arakawa; Makiko Ueda
Journal:  J Gastroenterol       Date:  2010-04-02       Impact factor: 7.527

5.  Intralesional steroid injection therapy in the management of resistant gastrointestinal strictures.

Authors:  Rakesh Kochhar; Kuchhangi Suresh Poornachandra
Journal:  World J Gastrointest Endosc       Date:  2010-02-16

6.  Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats.

Authors:  Dov Wengrower; Giuliana Zanninelli; Giovanni Latella; Stefano Necozione; Issa Metanes; Eran Israeli; Joseph Lysy; Mark Pines; Orit Papo; Eran Goldin
Journal:  Can J Gastroenterol       Date:  2012-01       Impact factor: 3.522

Review 7.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 8.  Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Authors:  Giacomo Lanzoni; Giulia Roda; Andrea Belluzzi; Enrico Roda; Gian Paolo Bagnara
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

9.  Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.

Authors:  C Alexakis; J P Caruelle; A Sezeur; J Cosnes; J P Gendre; H Mosnier; L Beaugerie; D Gallot; M Malafosse; D Barritault; P Kern
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis.

Authors:  Dimitrios C Ziogas; Beatriz Gras-Miralles; Sarah Mustafa; Brenda M Geiger; Robert M Najarian; Jutta M Nagel; Sarah N Flier; Yury Popov; Yu-Hua Tseng; Efi Kokkotou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-28       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.